Status:
COMPLETED
Lansoprazole Versus Mosapride for Functional Dyspepsia
Lead Sponsor:
Lotung Poh-Ai Hospital
Collaborating Sponsors:
Tomorrow Medical Foundation
Conditions:
Functional Dyspepsia
Epigastric Pain Syndrome
Eligibility:
All Genders
20-90 years
Phase:
PHASE4
Brief Summary
Functional dyspepsia is a common symptom complex with significant impact on quality of life. There is no standard treatment for functional dyspepsia but therapeutic efficacy of proton pump inhibitor (...
Detailed Description
Eligible outpatients with presentation of dyspepsia are enrolled if they fulfilled the criteria of ROME III criteria. A trained assistant helps the eligible patients to complete the ROME III standard ...
Eligibility Criteria
Inclusion
- aged more than 20 years old
- diagnosis of functional dyspepsia by fulfilling Rome-III criteria
- outpatient
Exclusion
- aged less than 20 years
- organic lesions including ulcers, tumors, bleeding, vasculopathy or esophagitis as demonstrated on upper endoscopy
- concurrent illness with malignancy, diabetes mellitus, liver cirrhosis, renal failure or porphyria
- diagnosis of organic disease for dyspeptic symptoms by treating physicians
- history of abdominal surgery
- concurrent user of aspirin and NSAID
- history of allergy or severe side effects to lansoprazole or mosapride
- pregnant or lactating women
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
329 Patients enrolled
Trial Details
Trial ID
NCT00663897
Start Date
May 1 2008
End Date
September 1 2009
Last Update
October 9 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lotung Poh-Ai hospital
Lotung Town, Ilan County, Taiwan, 26546